T. Ahlert

880 total citations
12 papers, 717 citations indexed

About

T. Ahlert is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, T. Ahlert has authored 12 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in T. Ahlert's work include Immunotherapy and Immune Responses (7 papers), Virus-based gene therapy research (6 papers) and Virology and Viral Diseases (3 papers). T. Ahlert is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Virus-based gene therapy research (6 papers) and Virology and Viral Diseases (3 papers). T. Ahlert collaborates with scholars based in Germany. T. Ahlert's co-authors include Volker Schirrmacher, G. Bastert, Roswitha Gerhards, C Haas, R Bonifer, Axel Hoos, D. Wallwiener, R. Heicappell, Paul von Hoegen and Markus Feuerer and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Trends in Molecular Medicine.

In The Last Decade

T. Ahlert

12 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Ahlert Germany 10 341 322 235 214 176 12 717
Jacob P. van Vloten Canada 15 215 0.6× 234 0.7× 238 1.0× 162 0.8× 163 0.9× 32 640
R Bonifer Germany 8 193 0.6× 131 0.4× 80 0.3× 96 0.4× 88 0.5× 10 386
Murielle Gantzer France 8 209 0.6× 620 1.9× 400 1.7× 544 2.5× 78 0.4× 13 915
Karishma Rajani United States 12 174 0.5× 320 1.0× 294 1.3× 144 0.7× 65 0.4× 22 500
Kyle B. Stephenson Canada 20 502 1.5× 778 2.4× 767 3.3× 385 1.8× 126 0.7× 27 1.3k
Nikolay Korokhov United States 16 214 0.6× 512 1.6× 294 1.3× 474 2.2× 78 0.4× 26 829
Helmut Bannert Germany 12 176 0.5× 154 0.5× 370 1.6× 269 1.3× 271 1.5× 17 795
Katsunori Shinozaki United States 12 143 0.4× 599 1.9× 195 0.8× 714 3.3× 201 1.1× 13 1.2k
Feorillo Galivo United States 17 396 1.2× 1.0k 3.2× 706 3.0× 443 2.1× 139 0.8× 21 1.3k
Sanae Nakayama Japan 17 145 0.4× 82 0.3× 392 1.7× 285 1.3× 430 2.4× 22 775

Countries citing papers authored by T. Ahlert

Since Specialization
Citations

This map shows the geographic impact of T. Ahlert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Ahlert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Ahlert more than expected).

Fields of papers citing papers by T. Ahlert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Ahlert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Ahlert. The network helps show where T. Ahlert may publish in the future.

Co-authorship network of co-authors of T. Ahlert

This figure shows the co-authorship network connecting the top 25 collaborators of T. Ahlert. A scholar is included among the top collaborators of T. Ahlert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Ahlert. T. Ahlert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fournier, Philippe, et al.. (2004). Importance of serine 200 for functional activities of the hemagglutinin-neuraminidase protein of Newcastle Disease Virus. International Journal of Oncology. 24(3). 623–34. 7 indexed citations
2.
Schirrmacher, Volker, Markus Feuerer, Philippe Fournier, et al.. (2003). T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity. Trends in Molecular Medicine. 9(12). 526–534. 64 indexed citations
3.
Schirrmacher, Volker, Markus Feuerer, Philipp Beckhove, T. Ahlert, & Viktor Umansky. (2002). T Cell Memory, Anergy and Immunotherapy in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 7(2). 201–208. 23 indexed citations
4.
Schirrmacher, Volker, et al.. (2001). Antitumor effects of Newcastle Disease Virus in vivo: Local versus systemic effects. International Journal of Oncology. 18(5). 945–52. 72 indexed citations
6.
Hoos, Axel, et al.. (1998). Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. International Journal of Cancer. 79(1). 8–12. 106 indexed citations
7.
Ahlert, T., Willi Sauerbrei, G. Bastert, et al.. (1997). Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.. Journal of Clinical Oncology. 15(4). 1354–1366. 93 indexed citations
8.
Ockert, D., Volker Schirrmacher, Erich Stoelben, et al.. (1996). Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.. PubMed. 2(1). 21–8. 108 indexed citations
9.
Schirrmacher, Volker, Thomas Lehnert, S. Pomer, et al.. (1995). Biotherapy of cancer. Journal of Cancer Research and Clinical Oncology. 121(8). 443–451. 9 indexed citations
10.
Ahlert, T. & Volker Schirrmacher. (1990). Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns.. PubMed. 50(18). 5962–8. 25 indexed citations
11.
Werner, Martin, T. Ahlert, & G. Bastert. (1989). Human monoclonal antibodies directed against ovarian carcinoma. Gynecologic Oncology. 34(2). 148–154. 4 indexed citations
12.
Heicappell, R., et al.. (1986). Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects. International Journal of Cancer. 37(4). 569–577. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026